Navigation Links
Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Date:1/6/2014

each different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to any of Arena's research and development may not meet regulatory requirements or otherwise be sufficient for further research and development, regulatory review or approval or continued marketing; Arena's ability to obtain and defend patents; the timing, success and cost of Arena's research and development; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; having adequate funds; and satisfactory resolution of litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersCindy McGee, Vice President,

David Schull, PresidentInvestor Relations & Alliance Management

david.schull@russopartnersllc.comcmcgee@arenapharm.com 

858.717.2310858.453.7200, ext. 1479
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
9. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
10. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
11. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , September 29, 2014 The ... 21.1 billion by 2018, recording a CAGR of 8.8% ... Delivery Devices Market - Global Industry Analysis, Size, Share, ... Research, a U.S.-based market intelligence company. The ... benefit from an increasing occurrence of cardiovascular diseases, diabetic ...
(Date:9/29/2014)... Based on its recent analysis of ... ADOCIA with the 2014 European Frost & Sullivan ... flexible business model that promotes partnerships and collaboration ... has managed to maintain a steady pace of ... "ADOCIA,s core technology is BioChaperone ® , which ...
(Date:9/29/2014)... , Sept. 29, 2014 Adaptive Biotechnologies, ... Generation Sequencing to profile the adaptive immune system, ... Advisory Board to provide strategic and clinical guidance ... of assays in the diagnosis and monitoring of ... of the SAB will be to support the ...
Breaking Medicine Technology:Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 2Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 3Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 4Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 2Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 3Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 4Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 5Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 6Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3
... ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse = function(data) ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var ...
... (Nasdaq: KOOLD ), a leading supplier of innovative ... said today that revenues for the fourth quarter of fiscal ... the same quarter a year ago. Revenues in the third ... Company recorded disposable revenues of $4.8 million in the fourth ...
Cached Medicine Technology:Creabilis Appoints George F. Horner III as its Chairman 2Creabilis Appoints George F. Horner III as its Chairman 3Creabilis Appoints George F. Horner III as its Chairman 4Creabilis Appoints George F. Horner III as its Chairman 5Creabilis Appoints George F. Horner III as its Chairman 6Creabilis Appoints George F. Horner III as its Chairman 7ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 2ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 3ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 4ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 5ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 6ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 7
(Date:9/30/2014)... (PRWEB) September 30, 2014 A trailblazer at ... and seeks out upcoming medical breakthroughs in spine repairs. ... has seen in his patients in which he has implanted ... and its components are state-of-the art and mimic normal human ... Mobi-C has also been proven to be an exceptional replacement ...
(Date:9/30/2014)... Influenza is a significant clinical and ... the efficacy of therapy, minimize overuse of antibiotics, conserve ... healthcare settings. Diagnostic tests available today vary widely in ... your laboratory makes in selecting the correct test, along ... key to effective use of influenza diagnostics. , ...
(Date:9/30/2014)... North Carolina (PRWEB) September 30, 2014 ... 200, a 203 mile relay race beginning in Raleigh, ... and awareness for Alzheimer’s support and care. , Associate ... Seniors Guide – the comprehensive senior resource for the ... 13 years. , Seniors Guide will be helping their ...
(Date:9/30/2014)... Dogs are social animals, and love to go everywhere with ... travelling from place to place. Many dog owners choose to ... this is not only unsafe for the dog, but unsafe ... shares with readers why keeping a dog restrained in a ... ways a dog can become injured by riding freely in ...
(Date:9/30/2014)... 30, 2014 Doctors often order breast ultrasounds ... results. Most breast ultrasounds are done at a specialized ... Imaging in Miami . The Center for Diagnostic Imaging ... to MRI. Most patients find ultrasounds to be more ... do not have to remain perfectly still. , ...
Breaking Medicine News(10 mins):Health News:Alere Webinar Spotlights Optimal Flu Diagnostics to Keep Your Lab Ahead of the Curve 2Health News:Alere Webinar Spotlights Optimal Flu Diagnostics to Keep Your Lab Ahead of the Curve 3Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 2Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 3Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 2Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 3Health News:Breast Ultrasounds Are a Comfortable and Convenient Option for Patients and Referring Doctors 2
... Nov. 19 2009 has been a monumental year ... "moneyvation," from QUITPLAN Services, QuitCash Challenge, helped the 31-year-old ... win The Challenge. Nearly 2,000 Minnesotans, including Doug, attempted ... to win the $5,000 grand prize. , On Thursday, ...
... , Official Statement by Teamsters General President Jim ... President Jim Hoffa issued the following statement today about the ... higher-cost health plans that will mean a huge middle-class tax ... that would impose an excise tax on insurers for higher-cost ...
... , FAIRFIELD, N.J., Nov. 19 Monogram Energy, Inc. ... completed the acquisition of Triad Therapeutics, Inc. ("Triad"), which ... the terms of the Stock Purchase and Recapitalization Agreement, ... of Triad in exchange for approximately 95% ownership to ...
... who directs the University of Southern California Center ... effort to evaluate robots as exercise coaches for adults ... elderly. The effort, entitled "Robot Motivator: Towards Adaptive ... influence of virtual social characters on people,s motivation to ...
... , New Video Educates Kids on How to Prevent ... learn the five things that they can do to prevent the ... a new music video released today by the Department of Health. ... the simple ways to prevent H1N1 flu in a manner that ...
... WASHINGTON, Nov. 19 Now that a bill has been ... of the Democratic Caucus to vote to allow debate to ... promise of quality, affordable health care for all. , "Majority ... forward," said USAction Program Director Alan Charney. "Now it,s time ...
Cached Medicine News:Health News:First-Time Father-to-Be Quits Smoking, Wins $5,000 in The QuitCash Challenge(TM) 2Health News:First-Time Father-to-Be Quits Smoking, Wins $5,000 in The QuitCash Challenge(TM) 3Health News:Monogram Energy, Inc. Acquires Triad Therapeutics, Inc. 2Health News:Pennsylvania Department of Health Releases H1N1 Flu Prevention Music Video 2Health News:60 Votes: Democratic Caucus Must Move Forward With Promise of Quality, Affordable Health Care for All With a Public Insurance Option 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: